Miller Anestesia

mic optic neuropathy is not associated with carotid

artery atherosclerosis. Stroke 24:539-542, 1993.

137. Danesh-Meyer HV, Levin LA: Erectile dysfunction

drugs and risk of anterior ischaemic optic neuropa-

thy: Casual or causal association? Br J Ophthalmol

91:1551-1555, 2007.

138. Stankiewicz JA: Complications of endoscopic sinus

surgery. Otolaryngol Clin North Am 22:749-758,

1989.

139. Stankiewicz JA: Complications of endoscopic intra-

nasal ethmoidectomy. Laryngoscope 97:1270-1273,

1987.

140. Hayreh SS: Anterior ischaemic optic neuropathy:

III. Treatment, prophylaxis, and differential diagno-

sis. Br J Ophthalmol 58:981-989, 1974.

141. Arnold AC, Levin LA: Treatment of ischemic optic

neuropathy. Semin Ophthalmol 17:39-46, 2002.

142. Colson P, Ryckwaert F, Coriat P: Renin angiotensin

system antagonists and anesthesia. Anesth Analg

89:1143-1155, 1999.

143. Gelman S, Mushlin PS: Catecholamine-induced

changes inthesplanchniccirculationaffectingsystemic

hemodynamics. Anesthesiology 100:434-439, 2004.

144. Grocott MP, Mythen MG, Gan TJ: Perioperative

fluid management and clinical outcomes in adults.

Anesth Analg 100:1093-1106, 2005.

145. Heimer L: Visual system. In: The Human Brain and

Spinal Cord. Functional Neuroanatomy and Dissec-

tion Guide. New York, Springer Verlag, 1983,

pp 271-286.

146. McKhann GM, Grega MA, Borowicz LM Jr, et al:

Stroke and encephalopathy after cardiac surgery:

An update. Stroke 37:562-571, 2006.

147. Taugher PJ: Visual loss after cardiopulmonary

bypass. Am J Ophthalmol 81:280-288, 1976.

148. Shahian DM, Speert PK: Symptomatic visual defi-

cits after open heart operations. Ann Thorac Surg

48:275-279, 1989.

149. Shaw PJ, Bates D, Cartlidge NEF, et al: Neurologic

and neuropsychologic morbidity following major

surgery: Comparison of coronary artery bypass and

peripheral vascular surgery. Stroke 18:700-707,

1987.

150. Tettenborn B, Caplan LR, Sloan MA, et al: Postope-

rative brainstem and cerebellar infarcts. Neurology

43:471-477, 1993.

151. Roach GW, Kanchuger M, Mangano CM, et al:

McSPI Group: Multicenter Study of Perioperative

Ischemia Research Group and Education Founda-

tion Investigators: Adverse cerebral outcomes after

coronary bypass surgery. N Engl J Med 335:1857-

1863, 1996.

152. Newman MF, Mathew JP, Grocott HP, et al: Central

nervous system injury associated with cardiac

surgery. Lancet 368:694-703, 2006.

153. Roth S, Gillesberg I: Injuries to the visual system

and other sense organs.

Benumof JL, Saidman LJ

(eds): Anesthesia and Perioperative Complications,

2nd ed. St. Louis, Mosby, 1999, pp 377-408.

154. Siesjö BK: Pathophysiology and treatment of focal

cerebral ischemia. II: Mechanisms of damage and

treatment. J Neurosurg 77:337-354, 1992.

155. Hogue CW Jr, Sundt TM III, Goldberg M, et al:

Neurological complications of cardiac surgery: The

need for new paradigms in prevention and

treatment. Semin Thorac Cardiovasc Surg 11:105-

115, 1999.

156. Blauth CI, Cosgrove DM, Webb BW, et al: Atheroe-

mbolism from the ascending aorta: An emerging

problem in cardiac surgery. J Thorac Cardiovasc

Surg 103:1104-1112, 1992.

157. Harris DNF, Bailey SM, Smith PLC, et al: Brain swe-

lling in first hour after coronary artery bypass

surgery. Lancet 342:586-587, 1993.

158. Meyendorf R: Psychopatho-ophthalmology, gnostic

disorders, and psychosis in cardiac surgery: Visual

disturbances after open heart surgery. Arch Psy-

chiatr Nervenkr 232:119-135, 1982.

159. Russell RW, Bharucha N: The recognition and pre-

vention of border zone cerebral ischaemia during

cardiac surgery. Q J Med 47:303-323, 1978.

160. Pugsley W, Klinger L, Paschalis C, et al: The impact

of microemboli during cardiopulmonary bypass on

neuropsychological functioning. Stroke 25:1393-

1399, 1994.

161. Murkin JM: Neurologic complications in noncar-

diac surgery. Semin Cardiothorac Vasc Anesth

10:125-127, 2006.

162. Vaughan DG, Asbury T, Riordan-Eva P: General

Ophthalmology. Norwalk, CT, Appleton and Lange,

1995.

163. Gartner S, Billet E: Acute glaucoma: As a complica-

tion of general surgery. Am J Ophthalmol 45:668-

671, 1958.

164. Wang BC, Tannenbaum CS, Robertazzi RW: Acute

glaucoma after general surgery. JAMA 177:108-110,

1961.

165. Fazio DT, Bateman JB, Christensen RE: Acute angle-

closure glaucoma associated with surgical anesthe-

sia. Arch Ophthalmol 103:360-362, 1985.

166. Ceccarelli FE, Smith PC: Studies on fluid and elec-

trolyte alterations during transurethral prostatec-

tomy: II. J Urol 86:434-441, 1961.

167. Appelt GL, Benson GS, Corriere JN Jr: Transient

blindness: Unusual initial symptom of transurethral

prostatic resection reaction. Urology 13:402-404,

1979.

168. Larson TR: Rationale and assessment of minimally

invasive approaches to benign prostatic hyperplasia

therapy. Urology 59:12-16, 2002.

169. Hatch PD: Surgical and anaesthetic considerations

in transurethral resection of the prostate. Anaesth

Intensive Care 15:203-211, 1987.

170. Hamilton-Stewart PA, Barlow IM: Metabolic effects

of prostatectomy. J R Soc Med 82:725-728, 1989.

171. Agarwal R, Emmett M: The post-transurethral

resection of prostate syndrome: Therapeutic propo-

sals. Am J Kidney Dis 24:108-111, 1994.

172. Ovassapian A, Joshi CW, Brunner EA: Visual distur-

bances: An unusual symptom of transurethral pros-

tatic resection reaction. Anesthesiology 57:332-334,

1982.

173. Defalque RJ, Miller DW: Visual disturbances during

transurethral resection of the prostate. Can Anaesth

Soc J 22:620-621, 1975.

174. Roesch RP, Stoelting RK, Lingeman JE, et al:

Ammonia toxicity resulting from glycine absorp-

tion during a transurethral resection of the prostate.

Anesthesiology 58:577-579, 1983.

175. Peters KR, Muir J, Wingard DW: Intraocular pres-

sure after transurethral prostatic surgery. Anesthe-

siology 55:327-329, 1981.

176. Schneider SP, Fyffe REW: Involvement of GABA

and glycine in recurrent inhibition of spinal moto-

neurons. J Neurophysiol 68:397-406, 1992.

177. Renteria RC, Johnson J, Copenhagen DR: Need

rods? Get glycine receptors and taurine. Neuron

41:839-841, 2004.

178. Korol S, Leuenberger PM, Englert U, Babel J: In vivo

effects of glycine on retinal ultrastructure and ave-

raged electroretinogram. Brain Res 97:235-251,

1975.

179. Wang J, Creel DJ, Wong KC: Transurethral resection

of the prostate, serum glycine levels, and ocular

evoked potentials. Anesthesiology 70:36-41, 1989.

180. Wolf GL, Capuano C, Hartung J: Nitrous oxide

increases intraocular pressure after intravitreal

sulfur hexafluoride injection. Anesthesiology

59:547-548, 1983.

181. Vote BJ, Hart RH, Worsley DR, et al: Visual loss after

use of nitrous oxide gas with general anesthetic in

patients with intraocular gas still persistent up to 30

days after vitrectomy. Anesthesiology 97:1305-1308,

2002.

182. SeabergRR,FreemanWR,GoldbaumMH,Manecke

GR: Permanent postoperative vision loss associated

with expansion of intraocular gas in the presence of

a nitrous oxide-containing anesthetic. Anesthesio-

logy 97:1309-1310, 2002.

Pérdida de visión postoperatoria

2607

Seccíon VI

Cuidados postoperatorios